Fundz

MEDICINES for Malaria Venture Appoints Martin Fitchet MD as Chief Executive Officer

PRIVATEApr 18, 2024

Position

Chief Executive Officer

Company

MEDICINES for Malaria Venture

Martin Fitchet
BiotechnologyHealth CareNon Profit

Description

MEDICINES for Malaria Venture (MMV) has announced the appointment of Martin Fitchet MD as its new Chief Executive Officer. Martin brings over 25 years of experience across Pharmaceuticals, MedTech and Global Public Health and joins from Johnson & Johnson where he was most recently the Global Head of Global Public Health.

Other recent leadership changes in Non Profit and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at MEDICINES for Malaria Venture, and when

A new leader at MEDICINES for Malaria Venture brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day MEDICINES for Malaria Venture raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MEDICINES for Malaria Venture, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MEDICINES for Malaria Venture. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MEDICINES for Malaria Venture

About

MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MEDICINES for Malaria Venture changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for MEDICINES for Malaria Venture's next move

Learn about Strategic plan

MEDICINES for Malaria Venture changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.